Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study - Quiz - MDSpire

Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

  • By

  • Esther Kissling

  • Baltazar Nunes

  • Mariëtte Hooiveld

  • Iván Martínez-Baz

  • Susana Monge

  • Chris Robertson

  • Mirjam Knol

  • Noémie Sève

  • Ivan Mlinarić

  • Lisa Domegan

  • Ausenda Machado

  • Heather Whitaker

  • Mihaela Lazar

  • Adam Meijer

  • Theresa Enkirch

  • Itziar Casado

  • Gloria Pérez-Gimeno

  • Naoma William

  • Vincent Enouf

  • Sanja Kurečić Filipović

  • Adele McKenna

  • Ana Paula Rodrigues

  • Simon de Lusignan

  • Olivia-Carmen Timnea

  • Neus Latorre-Margalef

  • Jesús Castilla

  • Francisco Pozo

  • Mark Hamilton

  • Shirley Masse

  • Maja Ilić

  • Luca Basile

  • Joan O’Donnell

  • Raquel Guiomar

  • Maximilian Riess

  • Rodica-Manuela Popescu

  • Angela M C Rose

  • Nick Andrews

  • Sabrina Bacci

  • Lucia Pastore Celentano

  • Marta Valenciano

  • Alain Moren

  • Philippe Beutels

  • Niel Hens

  • on behalf of I-MOVE-COVID-19 and ECDC primary care study teams

  • November 17, 2025

  • 0 min

Share

Original Source(s)

Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

  • by Esther Kissling, Baltazar Nunes, Mariëtte Hooiveld, Iván Martínez-Baz, Susana Monge, Chris Robertson, Mirjam Knol, Noémie Sève, Ivan Mlinarić, Lisa Domegan, Ausenda Machado, Heather Whitaker, Mihaela Lazar, Adam Meijer, Theresa Enkirch, Itziar Casado, Gloria Pérez-Gimeno, Naoma William, Vincent Enouf, Sanja Kurečić Filipović, Adele McKenna, Ana Paula Rodrigues, Simon de Lusignan, Olivia-Carmen Timnea, Neus Latorre-Margalef, Jesús Castilla, Francisco Pozo, Mark Hamilton, Shirley Masse, Maja Ilić, Luca Basile, Joan O’Donnell, Raquel Guiomar, Maximilian Riess, Rodica-Manuela Popescu, Angela M C Rose, Nick Andrews, Sabrina Bacci, Lucia Pastore Celentano, Marta Valenciano, Alain Moren, Philippe Beutels, Niel Hens, on behalf of I-MOVE-COVID-19 and ECDC primary care study teams

  • November 17, 2025

Related Content

The U.S. Government and Gavi, the Vaccine Alliance

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19